Tempus Fugit, Investors Regret? Short Seller Targets AI Darling, Warns CEO Is 'Cash Out King' (UPDATED)

Tempus AI (TEM) shares are down 16.6% after Spruce Point Capital Management announced a short position, citing concerns about the management team's history of promoting companies that later disappointed shareholders and "suspicious" accounting practices. Spruce Point alleges aggressive accounting, minimal AI revenue despite rebranding, and questions the integrity of Tempus AI's product, suggesting a potential 50-60% downside risk. A Tempus AI spokesperson dismissed the report as inaccurate, emphasizing the company's strong financial performance and growth.

Analysis

Tempus AI (TEM) shares experienced a significant decline, falling 16.6% to $54.80, following the announcement of a short position by Spruce Point Capital Management. The short-seller's report, titled "The Tempest Surrounding Tempus AI," raises substantial concerns regarding the company's management, notably founder and CEO Eric Lefkofsky and his partner Brad Keywell, citing a history of promoting technology companies like Starbelly.com and Groupon (GRPN, down 94.5% since IPO) that subsequently underperformed, allegedly leaving shareholders at a disadvantage. Spruce Point further alleges "aggressive and suspicious" accounting practices at Tempus AI, including adjusted EBITDA calculations potentially inflated by a novel debt forgiveness structure and possible circular cash flows involving related parties. The report also highlights that despite rebranding from Tempus Labs to Tempus AI, AI-related revenue constitutes less than 2% of total revenue, questioning the substance of its AI narrative. Concerns were also raised about the integrity of Tempus AI's product based on demonstration videos and the presence of board members with connections to previous fraud allegations. Spruce Point projects a potential downside risk of 50% to 60% for TEM shares. In response, a Tempus AI spokesperson dismissed the report as containing "inaccurate information" and "hypotheticals," emphasizing the company's strong financial performance, growth, and commitment to leveraging AI in healthcare. Despite the day's sharp decline, Tempus AI's stock remains up approximately 62% year-to-date.

Key Decisions for Investors

• Investors should critically evaluate the detailed allegations made by Spruce Point Capital Management, particularly those concerning accounting practices, management's track record, and the disparity between AI branding and reported AI-derived revenue.
• Monitor Tempus AI's forthcoming responses for specific refutations of the short-seller's claims, beyond the initial general dismissal, and seek independent verification of financial reporting and product capabilities.
• Given the stock's significant year-to-date appreciation prior to this report and the serious nature of the allegations, investors may consider reassessing their risk exposure and the company's valuation, especially in light of the projected downside risk.